Insider Transactions in Q1 2024 at Onconova Therapeutics, Inc. (ONTX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2024
|
Steven M Fruchtman PRESIDENT, CHIEF EXECUTIVE OFF |
SELL
Payment of exercise price or tax liability
|
Direct |
8,727
-10.45%
|
$0
$0.9 P/Share
|
|
Mar 14
2024
|
Mark Patrick Guerin CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,591
-6.72%
|
$0
$0.9 P/Share
|
|
Mar 13
2024
|
Steven M Fruchtman PRESIDENT, CHIEF EXECUTIVE OFF |
BUY
Exercise of conversion of derivative security
|
Direct |
23,111
+21.67%
|
-
|
|
Mar 13
2024
|
Mark Patrick Guerin CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,666
+18.35%
|
-
|
|
Feb 07
2024
|
Steven M Fruchtman PRESIDENT, CHIEF EXECUTIVE OFF |
SELL
Payment of exercise price or tax liability
|
Direct |
9,212
-13.23%
|
$0
$0.67 P/Share
|
|
Feb 07
2024
|
Steven M Fruchtman PRESIDENT, CHIEF EXECUTIVE OFF |
BUY
Exercise of conversion of derivative security
|
Direct |
21,320
+23.44%
|
-
|
|
Feb 07
2024
|
Mark Patrick Guerin CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,443
-7.55%
|
$0
$0.67 P/Share
|
|
Feb 07
2024
|
Mark Patrick Guerin CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,900
+17.58%
|
-
|